ALS (motor neurone disease): open trials in Belgium

8 open trials have a site in Belgium. Registry data; only the trial team decides who can take part.

NCT07287397
Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
Trial Treatment · Phase 1/2 · Vector Y Therapeutics
UZ Leuven, Leuven
Registry updated 2026-10-30
NCT07322003
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
Trial Treatment · Phase 3 · Prilenia
UZ Leuven, Leuven
Registry updated 2026-10-27
NCT07023835
Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
Trial Treatment · Phase 2 · Zydus Therapeutics Inc.
UZ Leuven, Leuven
Registry updated 2026-09-01
NCT07595666
Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.
Trial Treatment · prof. dr. Koen Van Laere
UZ Leuven, Leuven
Registry updated 2026-05-19
2025-524002-16-00
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS (PREVAiLS)
Trial Treatment · Phase 3 · Ferrer Internacional S.A.
UZ Leuven, Leuven
Registry updated 2026-05-14
NCT07509125
Ultra-High Resolution PET in Aging, Neurodegeneration and Psychotic Disorders
Trial Treatment · Universitaire Ziekenhuizen KU Leuven
UZ Leuven, Leuven
Registry updated 2026-04-03
NCT07100119
A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis
Trial Treatment · Phase 1 · Eli Lilly and Company
UZ Leuven, Leuven
Registry updated 2026-03-06
NCT03127267
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Trial Treatment · Phase 3 · AB Science
University Hospital Leuven (UZ Leuven), Leuven
Registry updated 2025-09-12

All ALS (motor neurone disease) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error